Fennec Pharmaceuticals Inc (FENC): Next-Year EPS Estimate 284.78%
As of 2026-06-04, Fennec Pharmaceuticals Inc (FENC) has a next-year EPS growth estimate of 284.78%.
On 2026-05-24, analyst consensus for FENC's next-year EPS growth shifted from 266.46% to 284.78% — a positive change of 18.32 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at 175.10%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 284.78%
- EPS growth this year
- 175.10%
- EPS next quarter (est)
- $0.02
- Last price
- $9.16
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 284.78% | 175.10% | $0.02 | $9.16 |
| 2026-06-03 | 284.78% | 175.10% | $0.02 | $9.14 |
| 2026-06-02 | 284.78% | 175.10% | $0.02 | $9.98 |
| 2026-06-01 | 284.78% | 175.10% | $0.02 | $9.88 |
| 2026-05-31 | 284.78% | 175.10% | $0.02 | $9.93 |
| 2026-05-28 | 284.78% | 175.10% | $0.02 | $9.89 |
| 2026-05-27 | 284.78% | 175.10% | $0.02 | $9.97 |
| 2026-05-26 | 284.78% | 175.10% | $0.01 | $9.89 |
| 2026-05-25 | 284.78% | 175.10% | $0.01 | $9.93 |
| 2026-05-24 | 284.78% | 175.10% | $0.01 | $9.93 |
| 2026-05-21 | 266.46% | 178.10% | $0.01 | $9.97 |
| 2026-05-20 | 266.46% | 178.10% | $0.01 | $9.75 |
| 2026-05-19 | 266.46% | 178.10% | $0.01 | $9.76 |
| 2026-05-18 | 266.46% | 178.10% | $0.01 | $9.60 |
| 2026-05-17 | 266.46% | 178.10% | $0.01 | $9.75 |
| 2026-05-14 | 298.66% | 170.95% | $0.00 | $9.24 |
| 2026-05-13 | 565.97% | 136.19% | -$0.04 | $6.85 |
| 2026-05-12 | 565.97% | 136.19% | -$0.04 | $7.03 |
| 2026-05-11 | 565.97% | 136.19% | -$0.04 | $7.10 |
| 2026-05-10 | 565.97% | 136.19% | -$0.04 | $6.93 |
| 2026-05-07 | 565.97% | 136.19% | -$0.04 | $6.90 |
| 2026-05-06 | 565.97% | 136.19% | -$0.04 | $7.18 |
| 2026-05-05 | 565.97% | 136.19% | -$0.04 | $6.72 |
| 2026-05-04 | 565.97% | 136.19% | -$0.04 | $6.65 |
| 2026-05-03 | 565.97% | 136.19% | -$0.04 | $6.54 |
| 2026-04-30 | 565.97% | 136.19% | -$0.04 | $6.49 |
| 2026-04-29 | 565.97% | 136.19% | -$0.04 | $6.26 |
| 2026-04-28 | 565.97% | 136.19% | -$0.04 | $6.70 |
| 2026-04-27 | 565.97% | 136.19% | -$0.04 | $6.85 |
| 2026-04-26 | 565.97% | 136.19% | -$0.04 | $6.84 |
Recent News
- Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Fennec Pharmaceuticals Inc. Q4 2025 Earnings Call SummaryMoby
- Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ...GuruFocus.com
- Fennec Pharmaceuticals Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesNewsfile
- Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Fennec Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Fennec Pharmaceuticals Inc (FENC) has a next-year EPS growth estimate of 284.78%, based on analyst consensus.
When was the latest EPS estimate revision for FENC?▾
The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 266.46% to 284.78%.
What sector and industry does Fennec Pharmaceuticals Inc belong to?▾
Fennec Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. FENC appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Fennec Pharmaceuticals Inc (FENC) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports